IM Cannabis Raises US$1.31 Million Through Registered Direct Offering
Medical cannabis company IM Cannabis announced it has raised US$1.31 million through a registered direct offering of common shares. The company operates in Israel and Germany.
IM Cannabis Corp. (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, announced on September 23, 2026, that it has raised US$1.31 million through a registered direct offering of common shares.
The company stated it entered into securities purchase agreements with certain accredited investors. The offering priced on September 23, 2026.
IM Cannabis has not specified the exact use of the proceeds, but the company has previously outlined strategic goals, including expansion in European markets and enhancement of production capabilities.
The capital raised is intended to support the company's growth strategy and facilitate investments in operational development, aiming to strengthen its position in the international medical cannabis sector.